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Abstract
Background: Cerebral Palsy (CP) is a disorder of posture and movement due to a defect in the immature brain.
The use of robotic devices as alternative treatment to improve the gait function in patients with CP has increased.
Nevertheless, current gait trainers are focused on controlling complete joint trajectories, avoiding postural control
and the adaptation of the therapy to a specific patient. This paper presents the applicability of a new robotic
platform called CPWalker in children with spastic diplegia.
Findings: CPWalker consists of a smart walker with body weight and autonomous locomotion support and an
exoskeleton for joint motion support. Likewise, CPWalker enables strategies to improve postural control during
walking. The integrated robotic platform provides means for testing novel gait rehabilitation therapies in subjects
with CP and similar motor disorders. Patient-tailored therapies were programmed in the device for its evaluation
in three children with spastic diplegia for 5 weeks.
After ten sessions of personalized training with CPWalker, the children improved the mean velocity (51.94 ± 41.
97 %), cadence (29.19 ± 33.36 %) and step length (26.49 ± 19.58 %) in each leg. Post-3D gait assessments provided
kinematic outcomes closer to normal values than Pre-3D assessments.
Conclusions: The results show the potential of the novel robotic platform to serve as a rehabilitation tool. The
autonomous locomotion and impedance control enhanced the children’s participation during therapies. Moreover,
participants’ postural control was substantially improved, which indicates the usefulness of the approach based on
promoting the patient’s trunk control while the locomotion therapy is executed. Although results are promising,
further studies with bigger sample size are required.
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Background
One of the most important consequences of Cerebral
Palsy (CP) in children is mobility impairment, character-
ized by reduced speed and endurance or shortened step
length during gait [1]. In last decades, robot-based ther-
apy has complemented conventional strategies in CP gait
rehabilitation [2, 3]. Several rehabilitation devices have
been recently proposed with this aim [4, 5]. The majority
of these platforms (e.g. Lokomat [4], GT-1 [5]) includes
the approach of Partial Body-Weight Support (PBWS)
and guided and repetitive movement. However, therapies
carried out with common available devices are similar
for all subjects, despite the cognitive and physical differ-
ences among them make important to tailor the therapy
to the specific patient’s needs. Taking into account that
maintaining a proper posture during walking is a rele-
vant aspect in the case of children with CP [6, 7], new
strategies are needed to improve postural control while
over-ground movement is allowed.
In order to address these limitations, a novel robotic
platform (CPWalker [8]) has been designed. It can
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implement new types of therapies in children with CP.
The shift that CPWalker introduces on the treatments is
supported by three main pillars: a) the option of free
and over-ground movement (not restricted to treadmill)
in rehabilitation environment; b) the improvement of
postural control of head and trunk using a biofeedback
strategy; and c) the use of “Assist As Needed” (AAN)
strategies in specific and selected subtasks of walking.
Methods
Patients
Three pediatric patients with spastic diplegia (one
female), two suffering from spastic CP and one from
Hereditary Spastic Paraparesis (HSP), were recruited to
participate in this study (Table 1). The inclusion criteria
for the patient’s recruitment was: a) capable of under-
standing the proposed exercises; b) aged 11 to 18 years;
c) maximum weight 75 kg; d) children with no deforma-
tions that could prevent the use of the exoskeleton; e)
Gross Motor Function Classification System (GMFCS)
levels I to III; f ) able to signal pain or discomfort. The
exclusion criteria of this study was defined as: a)
unhealed skin lesions in the lower limbs; b) aggressive or
self-harming behaviors; c) severe cognitive impairment.
The clinical trial was carried out at “Hospital Infantil
Universitario Niño Jesús”. The Local Ethical Committee
of this hospital gave approval to the study, and war-
ranted its accordance with the Declaration of Helsinki.
All patients and families were informed beforehand, and
provided consent through parents to participate.
Experimental apparatus
The platform used in this study to help the users to re-
cover the gait function is the robotic trainer CPWalker
(Fig. 1) described in detail in [8]. CPWalker incorporates
actuators in both the walker and the exoskeleton, to
constitute an active rehabilitation robotic platform. The
included systems, showed in Fig. 1, are: a) a drive system
to provide the translation movement required for an am-
bulation treatment in real rehabilitation environments
instead of treadmill training; b) PBWS system to unload
the child from the ground with the therapeutic benefits
of improving balance and other characteristics such as
symmetry or stride length [9, 10]; c) a system for the
control of hip height, to adapt the robotic platform to
different anthropometric measures; and d) a six Degrees
Of Freedom (6-DOF) adjustable exoskeleton system for
providing guided movements in sagittal plane. A video
showing the experimentations with patients is available
in the Additional file 1.
Therapy
The training with CPWalker was performed for 5 weeks,
2 days per week (10 training sessions), with the exercise
time for each day set at 60 min, including 10 min of
setup time. The exercises consisted of walking with the
robotic device through routes in flat and straight lines
into the hospital facilities.
The therapies were individually adapted for each patient
aiming at enhancing the most affected region in each case
(according to the results of gait assessments done before
to start with robot-based therapies). Specifically, the treat-
ment defined for Patient 1 and Patient 3 attempted to im-
prove the postural control of the trunk during walking. As
a result, a stiffer impedance control of the lower limbs
joints was set to assist the users’ movement while they
were more focused on posture control using a biofeedback
strategy. On the other hand, with Patient 2 the main pur-
pose was to improve the range of motion (ROM) of the
hip joint, primarily the extension movement. In order to
address this rehabilitation, a less stiff impedance control of
this joint was adjusted to intensify Patient 2’s collaboration
in reaching the maximum extension of the hip. Given that
Table 1 Description of the patients
Patient Disease GMFCS Age Weight [kg]
Patient 1 Spastic diplegia-CP III 14 32
Patient 2 Spastic diplegia-CP II 12 40
Patient 3 Spastic diplegia-HSP - 13 43
Fig. 1 Final view of the CPWalker Platform. a Drive system which
provides free movement of the platform; b PBWS system that allow
the possibility of choosing the discharge of weight that support the
child’s lower limbs; c System for the control of hip height in order to
adapt the platform to different anthropometric measures; d Exoskeleton
system with actuated joints in hip and knee
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this child had rigid Ankle-Foot Orthoses (AFO), the ankle
joints were fixed to 90°. With no actuation on ankles, the
propulsion on the ground was not high enough, so we im-
posed position control to knee joints in order to achieve a
proper knee flexion. For this patient the biofeedback strat-
egy for postural control was set with a bigger tolerance,
which enabled the patient to be more focused on improv-
ing the hip movement.
With the aim of accommodating the patients to the
robotic platform and following therapists’ recommenda-
tions, all of them were completely suspended during the
first sessions (PBWS of 100 %), and the PBWS was grad-
ually decreased along the course of 5 weeks of the study
(Fig. 2). This approach allowed the subjects to gradually
get used to support their weight on their own legs. In
the same way, the percent of ROM applied for each joint
respect to a normal gait pattern (Fig. 2) and the gait
speed were updated during the therapy with the purpose
of increasing the difficulty of the exercise.
According to the pre-measured capabilities for each
child and following recommendations from our clinical
partners, the parameters were selected before to start
the robotic therapy (Table 2).
The designed therapies were based on two key fea-
tures: an interface to correct the user’s posture during
robot-assisted walking and a selective impedance control
to achieve the tailored therapy related to the patient’s
needs.
Fig. 2 Evolution of therapy parameters in Patient 1. a Percent of the range of motion of a healthy user programmed in the robot. b Percent of the
subject body weight supported by the platform. These parameters were adjusted during the treatment in order to tailor the therapy to each patient
Table 2 Selected parameters according to patients’ capabilities







Patient 1 80 100 100 50 0.172 0.210
Patient 2 85 90 100 60 0.159 0.210
Patient 3 73 88 100 65 0.133 0.188
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Fig. 3 IMUs based interface to give biofeedback of postural control in head and trunk. The graphics show IMUs data collected in real time for head and trunk in
three planes (blue lines), and these are compared with hip ROM (red lines). The red squares represent postures out of the limit values (acoustic feedback playing)
Table 3 Comparison between Pre and Post studies
Pre 3D analysis Post 3D analysis Normality
Patient Parameter Right side Left side Right side Left side
Patient 1 Mean velocity (m/s) 0.40 ± 0 0.49 ± 0 1.20 ± .20
Cadence (step/min) 73.80 ± 6.00 75.80 ± 7.97 129.60 ± 8.40
Step length (m) 0.30 ± .01 0.24 ± .04 0.33 ± .02 0.27 ± .01 0.58 ± .06
Trunk rotation Percentage range (max-min) 286.29 % 248.71 % 204.84 % 233.87 % 100 %
Maximum peak 14.83° 0° 4° 10° 4.80°
Minimum peak −2.92° −15.42° −8.70° −4.50° −2.40°
Patient 2 Mean velocity (m/s) 0.60 ± .10 0.80 ± 0 1.20 ± .20
Cadence (step/min) 102.20 ± 12.65 120.8 ± 9.38 129.60 ± 8.40
Step length (m) 0.31 ± .03 0.24 ± .05 0.40 ± .01 0.38 ± .02 0.58 ± .06
Hip ROM flex-ext Percentage range (max-min) 70.63 % 85.82 % 95.19 % 96.20 % 100 %
Maximum peak (flexion) 46.40° 48.40° 41.90° 39.50° 37.10°
Minimum peak (extension) 18.50° 14.50° 4.30° 1.50° −2.40°
Patient 3 Mean velocity (m/s) 0.20 ± 0 0.40 ± 0 1.20 ± .20
Cadence (step/min) 45 ± 3.70 75 ± .60 129.60 ± 8.40
Step length (m) 0.23 ± .05 0.30 ± .05 0.32 ± .02 0.33 ± .04 0.58 ± .06
Trunk rotation Percentage range (max-min) 343.55 % 350.48 % 224.52 % 234.35 % 100 %
Maximum peak 20° 2.60° 8.25° 6.28° 4.80°
Minimum peak −1.30° −19.13° −5.67° −8.25° −2.40°
Temporal, spatial parameters and kinematic data related with the selected improvements for each patient (correspondence with Fig. 4)
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Postural control therapy
The biofeedback strategy for postural control was based
on inertial measurement unit (IMU) sensors (Fig. 3).
Two IMU sensors, placed on the user’s chest and head,
measured the orientation of the trunk and head respect-
ively. The procedure based on this approach consisted in
giving acoustic feedback to the users when their trunk or
head were not in a proper position, which was defined by
the clinicians (see clinical interface on the left of Fig. 3).
The measures provided by this biofeedback strategy
were important during the execution of the therapy:
while the exoskeleton corrected the patients’ gait, the
postural control strategy motivated them to maintain a
proper posture during ambulation [6, 7, 11]. Figure 3-
right shows an example of recording data in real time
from IMUs-based system, where the measured angles
for head and trunk (blue lines) in three spatial planes
are compared to the ROM of the left hip during walking
(red lines). Red squares in Fig. 3-left represent posture
out of the permitted range and where acoustic feedback
was given.
Assist as needed therapy
The AAN philosophy was included into the control via a
selective impedance control strategy [12], which was
implemented in specific and selected subtasks during
walking therapy. This approach increased the patient’s
active participation during the exercise performance.
The method considers the interaction torque between
the user and the exoskeleton, allowing a variable devi-
ation from the predefined reference trajectories. As a
result, CPWalker attempts to prevent undesired efforts
on lower limbs and to take advantage of patient’s re-
sidual movements.
Results
Children’s 3D gait assessments without the aid of
CPWalker were conducted before and after the robot-
based therapy. This analysis provided kinematic data and
temporal-spatial parameters that were used to evaluate
the progression of the therapy.
After 5 weeks of robot-based training with CPWalker
system the three children improved the mean velocity,
cadence and step length with each leg (Table 3).
Additionally, taking into account the kinematic analysis,
the three subjects progressed in their gait as Fig. 4 and
Table 3 shown. Post-3D studies revealed that the trajec-
tories for right and left lower limbs are closer to the
normal values when compared to pre-3D studies. All
children succeeded the goals proposed on Table 2.
As the therapies were individually tailored for each
patient, the results have to be understood as separate
case studies.
Discussion and conclusion
This contribution has presented the importance of consid-
ering novel robot-based strategies for gait rehabilitation
and its previous results from a validation using the
CPWalker device with pediatric population. The strength
of the robotic platform used in this study is the capability
of AAN gait training with displacement in real environ-
ment while the apparatus provides feedback in order to
correct the child’s posture. These functions enabled the
definition of tailored therapies for each patient.
Although outcomes are quite promising, we acknow-
ledge that the population size of this pilot trial, the re-
duced time of intervention (only 10 sessions) and the
Fig. 4 Outcomes from kinematic analysis in Patient 1, 2 and 3 without
the robotic aid. The graphics show the improvements for each patient
depend on the focus of each therapy. Green lines are referred to right
side and Red lines to left side. Dashed lines correspond to 3D studies
done before the robotic treatment and Continuous lines to 3D studies
done after 5 weeks of robot-based therapy
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short-term follow up are the main limitations of this re-
search. Future work will be focused on performing a
proper clinical evaluation with an increased number of
patients. These studies are necessary to determine if
gains will have long-term and lasting impact for children
with CP and other similar disorders.
Additionally, we are currently evaluating the effective-
ness of a non-invasive way for promoting a more active
participation of central nervous system into the rehabili-
tation strategy in order to allow the implementation of a
“Top-Down” approach [13].
Additional file
Additional file 1: Video illustrating the rehabilitation process based on
the CPWalker robotic platform. (MP4 17260 kb)
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